It has also been observed that patients taking GLP-1 or GLP/GIP medications are at risk of losing lean muscle mass during weight loss, so it is important for patients to maintain adequate sources of protein in their diets
Keywords: GLP-1 receptor agonists, obesity, weight loss, non-diabetic patients, cardiovascular outcomes, cost-effectiveness Introduction Obesity is a chronic disease with high prevalence and associated comorbidities, making it a growing global concern [7] [8]
These tend to improve with extended use, yet can resurface as the doses of the medication are increased
Change spots by switching between your abdomen, thighs, and upper arms using a planned rotation
Try to pull up the same amount of air as you intend to take as your dose of medicine (ie, if youre planning to take 20 units of medicine, then draw up 20 units of air into the syringe prior to putting it in vial)
GLP-1 RAs arent approved for use in pregnancy at this time